Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Sprinzl, Martin; Kremer, Maximilian; Kohlwes, Elke et al.
HIGH-INTENSITY CONTRAST IMAGING ASSISTED HIGH-RESOLUTION ANOSCOPY WITH BLUE LIGHT IMAGING (BLI) FOR ANAL CARCINOMA SCREENING IN HIV INFECTED PATIENTSGASTROINTESTINAL ENDOSCOPY. Bd. 87. H. 6. 2018 S. AB381-AB381
Hopprich, Anne; Reinholz, Ulrike; Gerlach, Christina et al.
How to Identify the Inpatient's Palliative Care Needs in a Hemato-Oncological Ward: Ask the Nurses!JOURNAL OF PALLIATIVE MEDICINE. Bd. 21. H. 1. 2018 S. 4-5
Zhong, Xiaoxia; Prinz, Andreas; Steger, Julia et al.
HoxA9 transforms murine myeloid cells by a feedback loop driving expression of key oncogenes and cell cycle control genesBLOOD ADVANCES. Bd. 2. H. 22. 2018 S. 3137-3148
Holmer, Amadeus; Marotz, Joerg; Wahl, Philip et al.
Hyperspectral imaging in perfusion and wound diagnostics - methods and algorithms for the determination of tissue parametersBIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK. Bd. 63. H. 5. 2018 S. 547-556
Gopal, Ajay K.; Schuster, Stephen J.; Fowler, Nathan H. et al.
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN StudyJOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 23. 2018 S. 2405-+
Rule, S.; Jurczak, W.; Jerkeman, M. et al.
Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY studyLEUKEMIA. Bd. 32. H. 8. 2018 S. 1799-1803
Plaumann, Julian; Engelhardt, Melanie; Awwad, Mohamed H. S. et al.
IL-10 inducible CD8(+) regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cellsCANCER IMMUNOLOGY IMMUNOTHERAPY. Bd. 67. H. 11. 2018 S. 1695-1707
Qin, S.; Cheng, A-L.; Ducreux, M. P. et al.
IMbrave150: A randomised phase III study of atezolizumab 1 bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinomaANNALS OF ONCOLOGY. Bd. 29. 2018
Finn, Richard S.; Ducreux, Michel; Qin, Shukui et al.
IMbrave150: A randomized phase III study of 1L atezolizumab plus bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinoma.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018
Almstedt, K; Schmidt, M
Immuno-oncology in breast cancer – from diagnosis to therapychirurgische praxis. Bd. 83. 2018 S. 674-680